The comprehensive study of the absorption, distribution, metabolism, and excretion (ADME) of therapeutic peptides administered to the human body, focusing on their pharmacokinetics and pharmacodynamics within the endocrine system. Understanding this metabolism is essential for determining the optimal route of administration, dosing frequency, and the expected duration of biological effect for any given peptide. It ensures maximum clinical efficacy and safety.
Origin
This term merges “peptide therapy,” the clinical use of short amino acid chains, with “metabolism,” derived from the Greek metabole, meaning change or overthrow, which describes the chemical processes of life. This specialized area of study is crucial for the clinical translation of peptide research.
Mechanism
Peptides are typically administered via subcutaneous injection to bypass rapid enzymatic degradation in the gastrointestinal tract. Once in circulation, they are distributed to target tissues where they bind to specific receptors to exert their effect. The peptides are then metabolized by proteases and peptidases into smaller, inactive amino acid fragments, which are subsequently cleared, primarily by the kidneys. The half-life of a peptide, a key metabolic parameter, dictates its clinical utility.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.